Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
China Pioneer Pharma Holdings Ltd
1345Shanghai Pioneer Holding Ltd, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. The company offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas. It also sells medical devices, including ophthalmology, orthopedics, odontology, and wound care products. In addition, the company engages in sale of ancillary tools, dental devices, and imported in-licensed prescription products, as well as accessories leasing; research and development of denture and implants dentistry; Medical research and experimental development; and provision of metal finishing services. It sells its products to hospitals and medical institutions, and pharmacies. The company was formerly known as China Pioneer Pharma Holdings Limited. Shanghai Pioneer Holding Ltd was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pioneer Holding Ltd is a subsidiary of Pioneer Pharma (BVI) Co., Ltd. Address: No.15, Lane 88 Wuwei Road, Shanghai, China, 200331
Analytics
WallStreetin tavoitehinta
26.40 HKDP/E-suhde
16.79Osinkotuotto
3.07 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 1345
Osinkoanalytiikka 1345
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
153.00 %Osinkohistoria 1345
Osakkeen arvostus 1345
Talousasiat 1345
Tuloksia | 2019 | Dynamiikka |